TREAT-NMD
TREAT-NMD Coordination Office: T: +44 191 241 8605 Fax: +44 191 241 8770 E:
 |
TREAT-NMD is supported through Priority 1 (Life Sciences, Genomics and Biotechnology for Health) of the European Union’s FP6 under contract number LSHM-CT-2006-036825 |  |
- PARTNERS
- Partners
- Acies
- AFM/Institut de Myologie
- Biozentrum/University of Basel
- ENMC
- EURORDIS
- Fondazione Telethon
- Genethon
- Genosafe
- Helsingin yliopisto
- INSERM
- Karolinska Institute
- King's College London
- LUMC
- MRC
- MD-NET
- Clinical Trials Coordination Centre (CTCC)
- NIEH
- Newcastle University
- Santhera Pharmaceuticals
- Universitat Autonoma de Barcelona
- Universite Catholique de Louvain
- University College London
- DUCHENNE MUSCULAR DYSTROPHY
- Introduction
- DMD care standards
- DMD family guide
- DMD family guide in various languages
- Other care recommendations
- Patient registries
- DMD research overview
- - Gene therapy
- - Cell therapy
- - Drug therapy
- - Increasing muscle mass
- - Mutation-specific approaches
- Duchenne Research Reports
- DMD - Patient Organisations